As of Nov 25
| +0.044 / +4.94%|
The 4 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 0.75. The median estimate represents a +167.69% increase from the last price of 0.93.
The current consensus among 6 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.